Market Closed

EVGN
Evogene Ltd.
$ 0.3710
2.77%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Evogene Ltd. News

Latest Evogene Ltd. Stock News & EVGN Headlines

Evogene Schedules Third Quarter 2026 Financial Results Release
10 days ago | prnewswire.com
Evogene Announces Acute Graft-Versus-Host Disease (aGVHD) as the Target Indication for Its Internal AI-Driven Drug Discovery Program
18 days ago | prnewswire.com
Evogene to Participate in Upcoming BIO-Europe in Germany and Drug Discovery Chemistry Europe in Spain
20 days ago | prnewswire.com
Evogene to Participate in U.S. East Coast AI Drug Discovery Roadshow Organized by the Israel Export Institute and TradeIL
a month ago | prnewswire.com
Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors
a month ago | prnewswire.com
Critical Review: Evogene (NASDAQ:EVGN) vs. Allarity Therapeutics (NASDAQ:ALLR)
a month ago | defenseworld.net
Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance
2 months ago | prnewswire.com
EverGen to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto
2 months ago | newsfilecorp.com
Evogene Ltd. (NASDAQ:EVGN) Short Interest Down 77.2% in August
2 months ago | defenseworld.net
Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward
2 months ago | prnewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

EVGN
Evogene Ltd.
$ 0.3710
2.77%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago